Call for Abstract

2nd International Conference on Medicinal Chemistry & Computer Aided Drug Designing, will be organized around the theme “An Insight into the Present Day World of Medicinal Chemistry and Computer Aided Drug Designing”

MedChem & CADD-2013 is comprised of 12 tracks and 51 sessions designed to offer comprehensive sessions that address current issues in MedChem & CADD-2013.

Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.

Register now for the conference by choosing an appropriate package suitable to you.

  • Track 1-1Ligand based drug design
  • Track 1-2Structure based drug design
  • Track 1-3Drug design for nucleic acid targets
  • Track 1-4Drug design for GPCR targets
  • Track 2-1Modeling of protein structure
  • Track 2-2Use of high performance computing
  • Track 2-3Computer graphics in drug design
  • Track 2-4In silico molecular design software and tools
  • Track 2-5Use of X-ray crystallography and NMR spectroscopy in structure determination
  • Track 3-1Data mining and knowledge discovery
  • Track 3-2Toxicogenomics / Molecular mechanisms
  • Track 3-3Predicting environmental toxicity
  • Track 3-4Modeling environmental fate
  • Track 3-5Regulatory use and validation of QSAR
  • Track 3-6QSAR methods: Statistical analysis and physicochemical properties
  • Track 4-1Computer aided drug models in drug discovery
  • Track 4-2Using biomarkers for in silico drug development
  • Track 4-3Assessing the routes of drug administration
  • Track 4-4Computer models in drug delivery system
  • Track 4-53D models in prediction of side effects of drugs
  • Track 5-1Plant derived drugs in drug discovery
  • Track 5-2Microbial derived drugs in drug discovery
  • Track 5-3Chemical biology approach to drug discovery
  • Track 5-4Drug transporters in drug discovery
  • Track 5-5Drug discovery: Hit to lead
  • Track 6-1Advances in pharmacokinetic and pharmacodynamic interactions
  • Track 6-2Drug- drug interaction
  • Track 6-3Drug receptor interaction
  • Track 6-4Epidemiology of drug interactions
  • Track 7-1Novel therapies for the treatment of various diseases
  • Track 7-2Medication use in the elderly
  • Track 7-3Medication use during pregnancy
  • Track 8-1Herbalism
  • Track 8-2Crude drugs
  • Track 8-3Drugs from natural sources
  • Track 9-1CYP pharmacogenetics
  • Track 9-2Pharmacogenetics: From drug development to clinical practice
  • Track 9-3Pharmacogenomics in personalized medicine
  • Track 10-1Biological and therapeutic roles of glycine receptors
  • Track 10-2Cys-Loop receptor: Structure and function
  • Track 10-3TRP channels
  • Track 10-4Rho/Rho kinase signalling
  • Track 10-5Discovery and design of inhibitors
  • Track 11-1Identification of cause of adverse drug reactions
  • Track 11-2Predicting the safety profile of drugs
  • Track 11-3Toxicity and structural relationship
  • Track 12-1New small molecule approach for neglected diseases
  • Track 12-2Recent highlights in medicinal chemistry
  • Track 12-3New development in CNS drug research
  • Track 12-4New development in GPCR research
  • Track 12-5Recent highlights in cancer and AIDS diagnostics and treatment